MayTech Global Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
MayTech Global Investments's NVO Position: Q4 2025 in Review
MayTech Global Investments sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 387,083 shares — an estimated $21.5M sold.
MayTech Global Investments first reported a position in NVO in Q3 2022 and held it in 13 quarters. The position peaked at $32.5M in Q4 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- MayTech Global Investments reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- MayTech Global Investments sold 387,083 Novo Nordisk shares in Q4 2025, an estimated $21.5M.
- MayTech Global Investments first reported a position in Novo Nordisk in Q3 2022 and held it in 13 quarters.
- MayTech Global Investments's Novo Nordisk position peaked at $32.5M in Q4 2024.
- 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on MayTech Global Investments's 13F filing for Q4 2025, filed 13 Feb 2026.